Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a nutritional shake keep older adults strong and sharp?

NCT ID NCT07815158

Prevention Sponsor: National Yang Ming Chiao Tung University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing a daily nutritional powder to see if it can improve physical function, thinking, and metabolic health in people aged 65 and older. The formula contains proteins, vitamins, minerals, and plant compounds. For 12 weeks, participants will drink either the formula or a placebo powder, and researchers will measure changes in walking speed, grip strength, memory, and blood markers. The goal is to learn whether this supplement can help maintain independence and health in older adults.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a multi-component nutritional formula containing proteins, vitamins, minerals, and plant extracts
What this could lead to
If the formula helps, it could offer a simple dietary way to support muscle strength, mobility, and thinking in older adults.
What could go wrong
This is a small, 12-week study. Any benefits may be modest or fade, and the formula might not work better than a placebo. Some people may experience digestive discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 65 years and older. 2. Intact consciousness and cognitive ability to understand and cooperate with the study protocol. 3. Capable of oral ingestion and self-administration of the study formula/placebo. 4. Meets at least one of the following priority recruitment criteria: 1. Screened positive for decline in at least one WHO ICOPE intrinsic capacity domain (locomotion, vitality, cognition, psychology, vision, or hearing). 2. Sarcopenia risk based on AWGS 2019 criteria: low handgrip strength (\<28 kg for men; \<18 kg for women), slow 6-meter gait speed (\<1.0 m/s), or Short Physical Performance Battery (SPPB) score ≤ 9. 5. Ability to attend scheduled hospital outpatient visits at baseline (Week 0) and Week 12. 6. Willing and able to provide written informed consent. Exclusion Criteria: 1. Severe hepatic impairment (GPT/ALT \> 3 times the upper limit of normal, or a confirmed diagnosis of liver cirrhosis). 2. Severe renal impairment (serum creatinine ≥ 2.0 mg/dL, eGFR \< 30 mL/min/1.73m², or a confirmed history of renal failure, chronic kidney disease, uremia, or dialysis). 3. Confirmed clinical diagnosis of dementia. 4. Active malignant neoplasms currently undergoing active oncological therapy (chemotherapy, radiotherapy, or targeted therapy). 5. Current use of oral anticoagulant medication (Warfarin) due to potential interactions with fish oil and vitamin K2. 6. Known allergy or hypersensitivity to any ingredient of the study product (dairy, soy, or fish sources). 7. High-dose supplementation with whey protein, fish oil, or botanical extracts within the past 3 months. 8. Presence of an active middle-ear implant or cochlear implant (to eliminate confounding factors during hearing assessments).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intrinsic capacity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Frailty Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intrinsic capacity Sarcopenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kaohsiung Veterans General Hospital

    Kaohsiung City, 813414, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.